Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0002045027-26-000002

President and COO acquired 18,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Davis Hugh M. · President and COO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Exercise or conversion : show line 1 in the form +18,675 45,425 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Exercise or conversion : show line 2 in the form Restricted Stock Units −18,675 56,025 D
Loading xslF345X05/form4-02052026_090256.xml…